 HONG KONG, March 15, 2021 PRNewswire -- Global Cord Blood Corporation NYSE: CO GCBC or the Company, Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated March 2, 2021 received by the Companys Board of Directors the Board from Alternate Ocean Investment Company Limited Alternate Ocean, pursuant to which Alternate Ocean, acting on behalf of the fund the Acquirer that it manages andor advises, proposes to acquire all of the outstanding ordinary shares of the Company for US5.00 per ordinary share in cash, subject to certain conditions. The Board has formed a special committee of independent directors who are not affiliated with Alternate Ocean the Special Committee to evaluate such proposal. 